"I love Spiderwort - Building the scaffolding of life "

2022-05-07 21:53:34

Skip to main contentFAQOpens in a new tabOpens in a new tabOpens in a new tabTechnologyProductsCelluBridgeCelluJuveAbout UsNewsContact UsTechnologyProductsCelluJuveCelluBridgeAbout UsNewsContact UsFAQOpens in a new tabOpens in a new tabOpens in a new tabSpiderwortBuilding the scaffolding of lifeSpiderwort is building the framework for the future of regenerative medicine through the development of innovative plant-based biomaterials that promote the repair and regeneration of living tissues, including the spinal cord. Share on Twitter Opens in a new tab Share on Facebook Opens in a new tab Share on LinkedIn Opens in a new tab Share via email Opens in a new tab Share on Twitter Opens in a new tab Share on Facebook Opens in a new tab Share on LinkedIn Opens in a new tab Share via email Opens in a new tab Technology Spiderwort’s proprietary technology uses cellulose-based biomaterials to engineer living scaffolds for a variety of groundbreaking regenerative medicine applications. Spiderwort’s AerocellTM and HydrocellTM technology platforms provide clinicians and research teams precise control over stiffness, shape, textures, long-range architectures, to stimulate and control tissue regeneration. ProductsSpiderwort’s proprietary plant-based scaffolding provides a framework for significant advances in regenerative medicine and tissue engineering. CelluBridgeCelluBridge™ is a cellulose-based scaffold that promotes the repair and regeneration of the spinal cord.Learn more about CelluBridge CelluJuveCelluJuve™ is a cellulose-based dermal filler that can assist with everything from injury recovery to cosmetic enhancement.Learn more about CelluJuve VideoAndrew Pelling Makes Ears Out of ApplesSpiderwort’s Chief Science Officer explains how a simple apple changed everything.Video Play button - Andrew Pelling Makes Ears Out of Apples News More News November 12, 2020FDA grants a Breakthrough Device Designation for Spiderwort Spinal Cord TechnologyNews Release May 27, 2020Spiderwort closes $2.5M USD Series Seed financing to continue work on transformative biomaterialsNews Release Hear More From UsOpens in a new tabOpens in a new tabOpens in a new tab7 Bayview Station RoadOttawa, OntarioK1Y 2C5283, boulevard Alexandre-Taché (F3006)Gatineau, QuébecJ9A 1L8TechnologyCelluBridgeCelluJuveAbout UsNewsFAQContact UsPartnership/InvestmentCareers© Spiderwort 2022 | All Rights ReservedPrivacyTerms and ConditionsAccessibility